Skip to main content
Log in

No evidence of genetic anticipation in a large family with Lynch syndrome

  • Original Article
  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Lynch syndrome is the commonest inherited cause of colorectal cancer (CRC). Genetic anticipation occurs when the age of onset of a disorder decreases in successive generations. It is controversial whether this occurs in Lynch syndrome. Previous studies have included heterogenous groups of subjects from multiple families, including subjects with a clinical diagnosis (based on family history) as well as those with proven germline mismatch repair gene mutations. The purpose of this study was to determine whether genetic anticipation occurs in mismatch repair gene carriers from a single Lynch syndrome family. This study includes members of a single family known to carry an MLH1 gene mutation who are proven germline mutation carriers or obligate carriers (based on their offspring’s mutation status). Evidence of genetic anticipation (determined by age of onset of first CRC) was sought in two ways: Firstly, subjects were grouped as parent-child pairs and individuals were compared with their own offspring; secondly they were grouped by generation within the family tree. The Kaplan–Meier technique was used to adjust for variable follow up times. The family tree consisted of 714 subjects. Ninety-two subjects over five generations were included in the study. There was no evidence of genetic anticipation over the generations. (P = 0.37). Similarly, in the 75 parent–child pairs identified, age of onset of CRC was similar for parents and children (P = 0.51). We could not identify any evidence of genetic anticipation in mutation carriers from a single family with Lynch syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Watson P, Riley B (2005) The tumor spectrum in the Lynch syndrome. Fam Cancer 4(3):245–248

    Article  PubMed  Google Scholar 

  2. Stupart DA, Goldberg PA, Algar U, Ramesar R (2009) Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation. Fam Cancer 8(4):519–523

    Article  CAS  PubMed  Google Scholar 

  3. Warthin AS (1925) The further study of a cancer family. J Cancer Res 9:279–286

    Google Scholar 

  4. Gruber SB, Mukherjee B (2009) Anticipation in lynch syndrome: still waiting for the answer. J Clin Oncol 27(3):326–327

    Article  PubMed  Google Scholar 

  5. Vasen HF, Taal BG, Griffioen G, Nagengast FM, Cats A, Menko FH, Oskam W, Kleibeuker JH, Offerhaus GJ, Khan PM (1994) Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols. Gut 35(9):1262–1266

    Article  CAS  PubMed  Google Scholar 

  6. Rodríguez-Bigas MA, Lee PH, O’Malley L, Weber TK, Suh O, Anderson GR, Petrelli NJ (1996) Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum 39(6):649–653

    Article  PubMed  Google Scholar 

  7. Tsai YY, Petersen GM, Booker SV, Bacon JA, Hamilton SR, Giardiello FM (1997) Evidence against genetic anticipation in familial colorectal cancer. Genet Epidemiol 14(4):435–446

    Article  CAS  PubMed  Google Scholar 

  8. Voskuil DW, Vasen HF, Kampman E, van’t Veer P & National Collaborative Group on HNPCC (1997) Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations. Int J Cancer 72(2):205–9

    Google Scholar 

  9. Westphalen AA, Russell AM, Buser M, Berthod CR, Hutter P, Plasilova M, Mueller H, Heinimann K (2005) Evidence for genetic anticipation in hereditary non-polyposis colorectal cancer. Hum Genet 116(6):461–465. Epub 2005 Mar 17

    Google Scholar 

  10. Stella A, Surdo NC, Lastella P, Barana D, Oliani C, Tibiletti MG, Viel A, Natale C, Piepoli A, Marra G, Guanti G (2007) Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC. Clin Genet 71(2):130–139

    Article  CAS  PubMed  Google Scholar 

  11. Larsen K, Petersen J, Bernstein I, Nilbert M (2009) A parametric model for analyzing anticipation in genetically predisposed families. Stat Appl Genet Mol Biol 8: Article 26

  12. Nilbert M, Timshel S, Bernstein I, Larsen K (2009) Role for genetic anticipation in Lynch syndrome. J Clin Oncol 27(3):360–364

    Article  PubMed  Google Scholar 

  13. Boonstra PS, Gruber SB, Raymond VM, Huang SC, Timshel S, Nilbert M, Mukherjee B (2010) A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome. Genet Epidemiol 34(7):756–768

    Article  PubMed Central  PubMed  Google Scholar 

  14. Rubinsztein DC, Amos W, Leggo J, Goodburn S, Ramesar RS, Old J, Bontrop R, McMahon R, Barton DE, Ferguson-Smith MA (1994) Mutational bias provides a model for the evolution of Huntington’s disease and predicts a general increase in disease prevalence. Nat Genet 7(4):525–530

    Article  CAS  PubMed  Google Scholar 

  15. Bryer A, Krause A, Bill P, Davids V, Bryant D, Butler J, Heckmann J, Ramesar R, Greenberg J (2003) The hereditary adult-onset ataxias in South Africa. J Neurol Sci 216(1):47–54

    Article  PubMed  Google Scholar 

  16. Ramesar RS, Bardien S, Beighton P, Bryer A (1997) Expanded CAG repeats in spinocerebellar ataxia (SCA1) segregate with distinct haplotypes in South african families. Hum Genet 100(1):131–137

    Article  CAS  PubMed  Google Scholar 

  17. Ranum LP, Chung MY, Banfi S, Bryer A, Schut LJ, Ramesar R, Duvick LA, McCall A, Subramony SH, Goldfarb L et al (1994) Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset. Am J Hum Genet 55(2):244–252

    CAS  PubMed Central  PubMed  Google Scholar 

  18. Bozzao C, Lastella P, Stella A (2011) Anticipation in lynch syndrome: where we are where we go. Curr Genomics 12(7):451–465

    Article  CAS  PubMed  Google Scholar 

  19. Manley K, Shirley TL, Flaherty L, Messer A (1999) Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Nat Genet 23(4):471–473

    Article  CAS  PubMed  Google Scholar 

  20. Tabori U, Nanda S, Druker H, Lees J, Malkin D (2007) Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Cancer Res 67(4):1415–1418

    Article  CAS  PubMed  Google Scholar 

  21. Bozzao C, Lastella P, Ponz de Leon M, Pedroni M, Di Gregorio C, D’Ovidio FD, Resta N, Prete F, Guanti G, Stella A (2011) Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome. Cancer 117(18):4325–4335

    Article  CAS  PubMed  Google Scholar 

  22. Picco MF, Goodman S, Reed J, Bayless TM (2001) Methodologic pitfalls in the determination of genetic anticipation: the case of Crohn disease. Ann Intern Med 134(12):1124–1129

    Article  CAS  PubMed  Google Scholar 

  23. Stupart DA, Goldberg PA, Algar U, Ramesar R (2009) Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation. Colorectal Dis 11(2):126–130

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Stupart.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stupart, D., Goldberg, P., Algar, U. et al. No evidence of genetic anticipation in a large family with Lynch syndrome. Familial Cancer 13, 29–34 (2014). https://doi.org/10.1007/s10689-013-9669-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-013-9669-0

Keywords

Navigation